Sign in

CIK 0001479419

  • Non-accelerated filer
  • Smaller reporting company

KALA BIO, Inc.

Sign in to watch
Ticker
KALA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
270604595
Phone
+1 781-996-5252
Business address
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
Former names
KALA BIO, Inc., Kala Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 46 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-06-17 Shah Rajeev M. Director Grant or award +20,000 20,000
2021-06-17 Rosen Howard B Director Grant or award +20,000 44,824
2021-06-17 PERRY GREGORY D Director Grant or award +20,000 40,000
2021-06-17 Paull Robert Bradley Director Grant or award +20,000 40,000
2021-06-17 KOVEN ANDREW I Director Grant or award +25,000 53,000
2021-06-17 Grunberg Gregory Director Grant or award +20,000 40,000
2021-04-01 RA CAPITAL MANAGEMENT, L.P. Director Other acquisition +279,846 $6.74 $1.9M 279,846
2021-04-01 RA CAPITAL MANAGEMENT, L.P. Director Other acquisition +1,407,863 $6.74 $9.5M 10,594,767
2021-03-01 Chen Hongming Chief Scientific Officer Exercise or conversion +9,500 $2.30 $22K 243,015
2021-03-01 Chen Hongming Chief Scientific Officer Exercise or conversion · Stock Option (right to buy −9,500 53,736
2021-02-25 Chen Hongming Chief Scientific Officer Exercise or conversion +47,000 $2.30 $108K 233,515
2021-02-25 Chen Hongming Chief Scientific Officer Exercise or conversion · Stock Option (right to buy) −47,000 63,236
2021-01-04 Brazzell Romulus K Chief Medical Officer Grant or award +27,500 303,996
2021-01-04 Brazzell Romulus K Chief Medical Officer Grant or award · Stock Option (right to buy) +110,000 110,000
2021-01-04 Chen Hongming Chief Scientific Officer Grant or award +22,666 186,515
2021-01-04 Chen Hongming Chief Scientific Officer Grant or award · Stock Option (right to buy) +90,667 90,667
2021-01-04 Trachtenberg Eric Grant or award +22,666 128,567
2021-01-04 Trachtenberg Eric Grant or award · Stock Option (right to buy) +90,667 90,667
2021-01-04 Bazemore Todd Chief Operating Officer Grant or award +27,500 137,500
2021-01-04 Bazemore Todd Chief Operating Officer Grant or award · Stock Option (right to buy) +110,000 110,000

Page 15 of 19 · 378 trades